Intervention 1: Control group: Patients treated with risperidone at a dose of 4-6 mg along with placebo. Intervention 2: Intervention group: Patients treated with risperidone at a dose of 4-6 mg along

2 trials

Sponsors

Tehran University of Medical Sciences

Conditions

Schizophrenia. Schizophrenia

Phase 3

Fampridine for the treatment of schizophrenia

Active, not recruitingIRCT20090117001556N163

Tehran University of Medical SciencesSchizophrenia. Schizophrenia

Start: 2025-09-23Target: 50Updated: 2025-08-19

Agomelatine for the treatment of schizophrenia

Active, not recruitingIRCT20090117001556N164

Tehran University of Medical SciencesSchizophrenia. Schizophrenia

Start: 2025-09-23Target: 50Updated: 2025-08-19